Skip Navigation
Skip to contents

Cancer Res Treat : Cancer Research and Treatment

OPEN ACCESS

Search

Page Path
HOME > Search
7 "Jong-Hyock Park"
Filter
Filter
Article category
Keywords
Publication year
Authors
Funded articles
Original Articles
Health-Related Quality of Life Changes in Prostate Cancer Patients after Radical Prostatectomy: A Longitudinal Cohort Study
Dong Wook Shin, Sang Hyub Lee, Tae-Hwan Kim, Seok Joong Yun, Jong Kil Nam, Seung Hyun Jeon, Seung Chol Park, Seung Il Jung, Jong-Hyock Park, Jinsung Park
Cancer Res Treat. 2019;51(2):556-567.   Published online July 16, 2018
DOI: https://doi.org/10.4143/crt.2018.221
AbstractAbstract PDFSupplementary MaterialPubReaderePub
Purpose
Health-related quality of life (HRQOL) information related to radical prostatectomy (RP) is valuable for prostate cancer (PC) patients needing to make treatment decisions. We aimed to investigate HRQOL change in PC patients who underwent three types of RP (open, laparoscopic, or robotic) and compared their HRQOL with that of general population.
Materials and Methods
Patients were prospectively recruited between October 2014 and December 2015. European Organization for Research and Treatment of Cancer Quality-of-Life Questionnaire (EORTC QLQ-C30) and PC-specific module (PR25) were administered before surgery (baseline) and at postoperative 3 and 12 months. At each time point, HRQOL was compared, and a difference of 10 out of 0-100 scale was considered clinically significant.
Results
Among 258 screened patients, 209 (41 open, 63 laparoscopic, and 105 robotic surgeries) were included. Compared to baseline, physical, emotional, and cognitive functioning improved at 12 months. Role functioning worsened at 3 months, but recovered to baseline at 12 months. Pain, insomnia, diarrhea, and financial difficulties also significantly improved at 12 months. Most PR25 scales excluding bowel symptoms deteriorated at 3 months. Urinary symptoms and incontinence aid recovered at 12 months, whereas sexual activity and sexual function remained poor at 12 months. Clinically meaningful differences in HRQOL were not observed according to RP modalities. Compared to the general population, physical and role functioning were significantly lower at 3 months, but recovered by 12 months. Social functioning did not recover.
Conclusion
Most HRQOL domains showed recovery within 12 months after RP, excluding sexual functioning and social functioning. Our findings may guide patients considering surgical treatment for PC.

Citations

Citations to this article as recorded by  
  • Quality of life after robotic versus conventional minimally invasive cancer surgery: a systematic review and meta-analysis
    Russell Seth Martins, Asad Saulat Fatimi, Omar Mahmud, Muhammad Umar Mahar, Arshia Jahangir, Kinza Jawed, Shalni Golani, Ayra Siddiqui, Syed Roohan Aamir, Ali Ahmad
    Journal of Robotic Surgery.2024;[Epub]     CrossRef
  • The Effect of Discharge Education and Post-Discharge Telephone Counseling on Quality of Life in Patients Undergoing Radical Prostatectomy: A Randomized Controlled Study
    İpek Köse Tosunöz, Sevgi Deniz Doğan, Şeyma Yurtseven, Sevban Arslan
    Cukurova Anestezi ve Cerrahi Bilimler Dergisi.2024; 7(3): 205.     CrossRef
  • Health‐related quality of life the first year after a prostate cancer diagnosis a systematic review
    Louise Dorner Østergaard, Mads Hvid Poulsen, Malene Eiberg Jensen, Lars Lund, Malene Grubbe Hildebrandt, Birgitte Nørgaard
    International Journal of Urological Nursing.2023; 17(1): 15.     CrossRef
  • Quantitative Analysis of Quality of Life and Exploration of Influencing Factors in Patients Undergoing Radical Prostatectomy
    Feiyang Wang, Jiajun Chen, Weihao Wang, Mengyao Li, Chao Peng, Shouhua Pan, Chuanchuan Zhan, Keyuan Zhao, Yulei Li, Lulu Zhang, Gang Xu, Jing Jin
    Urology.2023; 181: 105.     CrossRef
  • Effects of omega‐3 supplementation on psychological symptoms in men with prostate cancer: Secondary analysis of a double‐blind placebo‐controlled randomized trial
    Josée Savard, Hanane Moussa, Jean‐François Pelletier, Pierre Julien, Louis Lacombe, Rabi Tiguert, Yves Caumartin, Thierry Dujardin, Paul Toren, Frédéric Pouliot, Michele Lodde, Yves Fradet, Karine Robitaille, Vincent Fradet
    Cancer Medicine.2023; 12(19): 20163.     CrossRef
  • Treatment Outcomes and Its Associated Factors Among Adult Patients with Selected Solid Malignancies at Kenyatta National Hospital: A Hospital-Based Prospective Cohort Study
    Amsalu Degu, Ermias Mergia Terefe, Eliab Seroney Some, Gobezie T Tegegne
    Cancer Management and Research.2022; Volume 14: 1525.     CrossRef
  • A systematic review of supervised comprehensive functional physiotherapy after radical prostatectomy
    B. Steenstrup, M. Cartier, F.X. Nouhaud, G. Kerdelhue, M. Gilliaux
    Progrès en Urologie.2022; 32(7): 525.     CrossRef
  • Perioperative psychological issues and nursing care among patients undergoing minimally invasive surgeries
    Kehua Yang, Xu Shao, Xinghui Lv, Feimin Yang, Qunyan Shen, Jing Fang, Wei Chen
    Laparoscopic, Endoscopic and Robotic Surgery.2022; 5(3): 92.     CrossRef
  • A Survey on the Quality of Life of Prostate Cancer Patients in Korean Prostate Cancer Patients Association
    Yun-Sok Ha, Kwang Taek Kim, Wook Nam, Hongzoo Park, Sangjun Yoo, Chan Ho Lee, Ho Seok Chung, Woo Suk Choi, Jiyoun Kim, Jaeeun Shin, Jeong Hyun Kim, Cheol Kwak
    The Korean Journal of Urological Oncology.2022; 20(4): 265.     CrossRef
  • Effects of leuprolide acetate on the quality of life of patients with prostate cancer: A prospective longitudinal cohort study
    Myung Soo Kim, Seung Il Jung, Ho Seok Chung, Eu Chang Hwang, Dongdeuk Kwon
    Prostate International.2021; 9(3): 132.     CrossRef
  • Quality of life assessment using EORTC QLQ questionnaires in the prostate cancer population treated with radical prostatectomy: a systematic review
    Tomasz Jurys, Jacek Durmala
    Scandinavian Journal of Urology.2021; 55(2): 90.     CrossRef
  • Évaluation de l’observance et de l’adhésion thérapeutique de deux protocoles de rééducation après prostatectomie
    Benoit Steenstrup, Claire Breton, Guillaume Galliou, François-Xavier Nouhaud
    Kinésithérapie, la Revue.2021; 21(234): 12.     CrossRef
  • Metabolic syndrome, levels of androgens, and changes of erectile dysfunction and quality of life impairment 1 year after radical prostatectomy
    Yann Neuzillet, Mathieu Rouanne, Jean-François Dreyfus, Jean-Pierre Raynaud, Marc Schneider, Morgan Roupret, Sarah Drouin, Marc Galiano, Xavier Cathelinau, Thierry Lebret, Henry Botto
    Asian Journal of Andrology.2021; 23(4): 370.     CrossRef
  • The Effect of Post-prostatectomy Urinary Incontinence on Health-related Quality of Life in Patients with Prostate Cancer
    Jeong Hyun Kim, Yeon Soo Jang, Young Deuk Choi, Eui Geum Oh
    Korean Journal of Adult Nursing.2019; 31(3): 293.     CrossRef
  • Prostate-specific health-related quality of life and patient-physician communication — A 3.5-year follow-up
    Nicole Ernstmann, Jan Herden, Lothar Weissbach, André Karger, Kira Hower, Lena Ansmann
    Patient Education and Counseling.2019; 102(11): 2114.     CrossRef
  • 10,071 View
  • 294 Download
  • 14 Web of Science
  • 15 Crossref
Close layer
Medical Travel among Non-Seoul Residents to Seek Prostate Cancer Treatment in Medical Facilities of Seoul
Jae Heon Kim, So Young Kim, Seok-Joong Yun, Jae Il Chung, Hoon Choi, Ho Song Yu, Yun-Sok Ha, In-Chang Cho, Hyung Joon Kim, Hyun Chul Chung, Jun Sung Koh, Wun-Jae Kim, Jong-Hyock Park, Ji Youl Lee
Cancer Res Treat. 2019;51(1):53-64.   Published online February 20, 2018
DOI: https://doi.org/10.4143/crt.2017.468
AbstractAbstract PDFSupplementary MaterialPubReaderePub
Purpose
This study aims to investigate the trend in medical travel by non-Seoul residents to Seoul for treatment of prostate cancer and also to investigate the possible factors affecting the trend.
Materials and Methods
This study represents a retrospective cohort study using data from theKoreanNationalHealth Insurance System from 2002 to 2015. Annual trends were produced for proportions of patients who traveled according to the age group, economic status and types of treatment. Multiple logistic analysiswas used to determine factors affecting surgeries at medical facilities in Seoul among the non-Seoul residents.
Results
A total of 68,543 patients were defined as newly diagnosed prostate cancer cohorts from 2005 to 2014. The proportion of patients who traveled to Seoul for treatment, estimated from cases with prostate cancer-related claims, decreased slightly over 9 years (28.0 at 2005 and 27.0 at 2014, p=0.02). The average proportion of medical travelers seeking radical prostatectomy increased slightly but the increase was not statistically significant (43.1 at 2005 and 45.4 at 2014, p=0.26). Income level and performance ofrobot-assisted radical prostatectomy were significant positive factors for medical travel to medical facilities in Seoul. Combined comorbidity diseases and year undergoing surgery were significant negative factors for medical travel to medical facilities in Seoul.
Conclusion
The general trend of patients travelling from outside Seoul for prostate cancer treatment decreased from 2005 to 2014. However, a large proportion of traveling remained irrespective of direct distance from Seoul.

Citations

Citations to this article as recorded by  
  • Relationship between patient outcomes and patterns of fragmented cancer care in older adults with gastric cancer: A nationwide cohort study in South Korea
    Dong-Woo Choi, Seungju Kim, Sun Jung Kim, Dong Wook Kim, Kwang Sun Ryu, Jae Ho Kim, Yoon-Jung Chang, Kyu-Tae Han
    Journal of Geriatric Oncology.2024; 15(2): 101685.     CrossRef
  • Analysis of trend in the role of national and regional hubs in prostatectomy after prostate cancer diagnosis in the past 5 years: A nationwide population-based study
    Seong Cheol Kim, Seungbong Han, Ji Hyung Yoon, Sungchan Park, Kyung Hyun Moon, Sang Hyeon Cheon, Gyung-Min Park, Taekmin Kwon
    Investigative and Clinical Urology.2024; 65(2): 124.     CrossRef
  • Domestic medical travel from non-Seoul regions to Seoul for initial breast cancer treatment: a nationwide cohort study
    Jae Ho Jeong, Jinhong Jung, Hee Jeong Kim, Jong Won Lee, Beom-Seok Ko, Byung Ho Son, Kyung Hae Jung, Il Yong Chung
    Annals of Surgical Treatment and Research.2023; 104(2): 71.     CrossRef
  • Symptom Experiences before Medical Help-Seeking and Psychosocial Responses of Patients with Esophageal Cancer: A Qualitative Study
    Hui Ge, Liang Zhang, Xuanxuan Ma, Wen Li, Shuwen Li, Pranshu Sahgal
    European Journal of Cancer Care.2023; 2023: 1.     CrossRef
  • Cancer care patterns in South Korea: Types of hospital where patients receive care and outcomes using national health insurance claims data
    Dong‐Woo Choi, Sun Jung Kim, Seungju Kim, Dong Wook Kim, Wonjeong Jeong, Kyu‐Tae Han
    Cancer Medicine.2023; 12(13): 14707.     CrossRef
  • Regional disparities in the availability of cancer clinical trials in Korea
    Jieun Jang, Wonyoung Choi, Sung Hoon Sim, Sokbom Kang
    Epidemiology and Health.2023; 46: e2024006.     CrossRef
  • Do Patients Residing in Provincial Areas Transport and Spend More on Cancer Treatment in Korea?
    Woorim Kim, Kyu-Tae Han, Seungju Kim
    International Journal of Environmental Research and Public Health.2021; 18(17): 9247.     CrossRef
  • Time Trends for Prostate Cancer Incidence from 2003 to 2013 in South Korea: An Age-Period-Cohort Analysis
    Hyun Young Lee, Do Kyoung Kim, Seung Whan Doo, Won Jae Yang, Yun Seob Song, Bora Lee, Jae Heon Kim
    Cancer Research and Treatment.2020; 52(1): 301.     CrossRef
  • Trends in Prostate Cancer Prevalence and Radical Prostatectomy Rate according to Age Structural Changes in South Korea between 2005 and 2015
    Hyun Young Lee, Suyeon Park, Seung Whan Doo, Won Jae Yang, Yun Seob Song, Jae Heon Kim
    Yonsei Medical Journal.2019; 60(3): 257.     CrossRef
  • Why is Life Expectancy in Busan Shorter than in Seoul? Age and Cause-Specific Contributions to the Difference in Life Expectancy between Two Cities
    Young-Ho Khang, Jinwook Bahk
    Yonsei Medical Journal.2019; 60(7): 687.     CrossRef
  • 10,809 View
  • 227 Download
  • 10 Web of Science
  • 10 Crossref
Close layer
Terminal Versus Advanced Cancer: Do the General Population and Health Care Professionals Share a Common Language?
Sang Hyuck Kim, Dong Wook Shin, So Young Kim, Hyung Kook Yang, Eunjoo Nam, Hyun Jung Jho, Eunmi Ahn, Be Long Cho, Keeho Park, Jong-Hyock Park
Cancer Res Treat. 2016;48(2):759-767.   Published online August 10, 2015
DOI: https://doi.org/10.4143/crt.2015.124
AbstractAbstract PDFPubReaderePub
Purpose
Many end-of-life care studies are based on the assumption that there is a shared definition of language concerning the stage of cancer. However, studies suggest that patients and their families often misperceive patients’ cancer stages and prognoses. Discrimination between advanced cancer and terminal cancer is important because the treatment goals are different. In this study, we evaluated the understanding of the definition of advanced versus terminal cancer of the general population and determined associated socio-demographic factors. Materials and Methods A total of 2,000 persons from the general population were systematically recruited. We used a clinical vignette of a hypothetical advanced breast cancer patient, but whose cancer was not considered terminal. After presenting the brief history of the case, we asked respondents to choose the correct cancer stage from a choice of early, advanced, terminal stage, and don’t know. Multinomial logistic regression analysis was performed to determine sociodemographic factors associated with the correct response, as defined in terms of medical context.
Results
Only 411 respondents (20.6%) chose “advanced,“ while most respondents (74.5%) chose “terminal stage” as the stage of the hypothetical patient, and a small proportion of respondents chose “early stage” (0.7%) or “don’t know” (4.4%). Multinomial logistic regression analysis found no consistent or strong predictor.
Conclusion
A large proportion of the general population could not differentiate advanced cancer from terminal cancer. Continuous effort is required in order to establish common and shared definitions of the different cancer stages and to increase understanding of cancer staging for the general population.

Citations

Citations to this article as recorded by  
  • A qualitative study on redefining normality in relatives of patients with advanced cancer
    Helen P. A. Driessen, Evi M. Bakker, Judith A. C. Rietjens, Khanh L. N. Luu, Marjolein Lugtenberg, Frederika E. Witkamp, Leonieke W. Kranenburg
    Cancer Medicine.2024;[Epub]     CrossRef
  • Prediction of prognosis in lung cancer using machine learning with inter-institutional generalizability: A multicenter cohort study (WJOG15121L: REAL-WIND)
    Daichi Fujimoto, Hidetoshi Hayashi, Kenta Murotani, Yukihiro Toi, Toshihide Yokoyama, Terufumi Kato, Teppei Yamaguchi, Kaoru Tanaka, Satoru Miura, Motohiro Tamiya, Motoko Tachihara, Takehito Shukuya, Yuko Tsuchiya-Kawano, Yuki Sato, Satoshi Ikeda, Shinya
    Lung Cancer.2024; 194: 107896.     CrossRef
  • Preserving the integrity of personhood in people with advanced cancer: An in-depth qualitative study among patients, relatives, and care professionals
    Alina Senßfelder, Matthias Havemann, Anna J Pedrosa Carrasco, Pia von Blanckenburg, Carola Seifart
    Palliative Medicine.2024; 38(9): 1054.     CrossRef
  • Complementary Musical Intervention for Patients in Palliative Care in Spain: A Randomized Controlled Trial
    Inmaculada Valero-Cantero, María Ángeles Vázquez-Sánchez, José Luis Casals-Sánchez, Milagrosa Espinar-Toledo, Juan Corral-Pérez, Cristina Casals
    Healthcare.2024; 12(19): 1938.     CrossRef
  • Challenges of Home Parenteral Nutrition for Patients with Advanced Cancer
    Soroor Fathi, Bahareh Aminnejad kavkani, Soheila Shekari, Samaneh Mirzaei Dahka, Naeemeh Hassanpour Ardekanizadeh, Golsa Khalatbari Mohseni, Maryam Gholamalizadeh, Kourosh Delpasand, Nasibe Jafarnia, Fatemeh Mohammadi-Nasrabadi, Saeid Doaei
    International Journal of Cancer Management.2023;[Epub]     CrossRef
  • Calibrating Natural History of Cancer Models in the Presence of Data Incompatibility: Problems and Solutions
    Olena Mandrik, Chloe Thomas, Sophie Whyte, James Chilcott
    PharmacoEconomics.2022; 40(4): 359.     CrossRef
  • End-of-life communication experiences within families of people with advanced cancer in China: A qualitative study
    Tianmeng Xu, Yuan Qin, Xiaohong Ou, Xiaowei Zhao, Pei Wang, Mengmeng Wang, Peng Yue
    International Journal of Nursing Studies.2022; 132: 104261.     CrossRef
  • Shock Index Is a Validated Prediction Tool for the Short-Term Survival of Advanced Cancer Patients Presenting to the Emergency Department
    Zhong Ning Leonard Goh, Mu-Wei Chen, Hao-Tsai Cheng, Kuang-Hung Hsu, Chen-Ken Seak, Joanna Chen-Yeen Seak, Seng Kit Ling, Shao-Feng Liao, Tzu-Heng Cheng, Yi-Da Sie, Chih-Huang Li, Hsien-Yi Chen, Cheng-Yu Chien, Chen-June Seak
    Journal of Personalized Medicine.2022; 12(6): 954.     CrossRef
  • Challenges in self‐management of persons living with advanced cancer: An exploratory, in‐depth interview study
    Hanna Noorlandt, Rik Stoevelaar, Sophie van Dongen, Muzeyyen Arslan, Nancy Luu, Leonieke Kranenburg, Erica Witkamp, Carin van der Rijt, Kate Lorig, Agnes van der Heide, Judith Rietjens
    European Journal of Cancer Care.2022;[Epub]     CrossRef
  • A qualitative meta-synthesis examining spirituality as experienced by individuals living with terminal cancer
    Lucy Hayden, Emma Byrne, Avril Deegan, Simon Dunne, Pamela Gallagher
    Health Psychology Open.2022;[Epub]     CrossRef
  • Home Parenteral Nutrition in Patients with Advanced Cancer: A Systematic Review and Meta-Analysis
    Francis J. O’Hanlon, Konstantinos C. Fragkos, Lucia Fini, Pinal S. Patel, Shameer J. Mehta, Farooq Rahman, Simona Di Caro
    Nutrition and Cancer.2021; 73(6): 943.     CrossRef
  • Strategies for living well with hormone-responsive advanced prostate cancer—a qualitative exploration
    Lauren Matheson, Jo Nayoan, Carol Rivas, Jo Brett, Penny Wright, Hugh Butcher, Paul Jordan, Anna Gavin, Adam Glaser, Malcolm Mason, Richard Wagland, Eila Watson
    Supportive Care in Cancer.2021; 29(3): 1317.     CrossRef
  • Cancer treatment resumption in patients with new-generation drug-eluting stents
    Dinu Valentin Balanescu, Moez Karim Aziz, Teodora Donisan, Nicolas Palaskas, Juan Lopez-Mattei, Saamir Hassan, Peter Kim, Juhee Song, William Ntim, Mehmet Cilingiroglu, Konstantinos Marmagkiolis, Cezar Iliescu
    Coronary Artery Disease.2021; 32(4): 295.     CrossRef
  • Physical Activity for Individuals Living with Advanced Cancer: Evidence and Recommendations
    Lauren C. Capozzi, Julia T. Daun, Manuel Ester, Stephen Mosca, David Langelier, George J. Francis, Eugene Chang, Daniel Santa Mina, Jack B. Fu, S. Nicole Culos-Reed
    Seminars in Oncology Nursing.2021; 37(4): 151170.     CrossRef
  • Shock Index: A Simple and Effective Clinical Adjunct in Predicting 60-Day Mortality in Advanced Cancer Patients at the Emergency Department
    Tzu-Heng Cheng, Yi-Da Sie, Kuang-Hung Hsu, Zhong Ning Leonard Goh, Cheng-Yu Chien, Hsien-Yi Chen, Chip-Jin Ng, Chih-Huang Li, Joanna Chen-Yeen Seak, Chen-Ken Seak, Yi-Tung Liu, Chen-June Seak
    International Journal of Environmental Research and Public Health.2020; 17(13): 4904.     CrossRef
  • Impact of prognostic nutritional index on terminal cancer patients
    AmrallahA Mohammed, Omar Al-Zahrani, FifiMostafa Elsayed
    Indian Journal of Palliative Care.2020; 26(4): 433.     CrossRef
  • Metastatic Breast Cancer as a Chronic Condition
    Patti Rager Zuzelo
    Holistic Nursing Practice.2019; 33(2): 125.     CrossRef
  • Experiences and Opinions Related to End-of-Life Discussion: From Oncologists' and Resident Physicians' Perspectives
    Su-Jin Koh, Shinmi Kim, JinShil Kim, Bhumsuk Keam, Dae Seog Heo, Kyung Hee Lee, Bong-Seog Kim, Jee Hyun Kim, Hye Jung Chang, Sun Kyung Baek
    Cancer Research and Treatment.2018; 50(2): 614.     CrossRef
  • End-of-life chemotherapy is associated with poor survival and aggressive care in patients with small cell lung cancer
    Yingming Zhu, Ke Tang, Fen Zhao, Yuanwei Zang, Xiaodong Wang, Zhenxiang Li, Xindong Sun, Jinming Yu
    Journal of Cancer Research and Clinical Oncology.2018; 144(8): 1591.     CrossRef
  • Consensus guidelines for the definition of the end stage of disease and last days of life and criteria for medical judgment
    Sang-Min Lee, Su-Jung Kim, Youn Seon Choi, Dae Seog Heo, Sujin Baik, Bo Moon Choi, Daekyun Kim, Jae Young Moon, So Young Park, Yoon Jung Chang, In Cheol Hwang, Jung Hye Kwon, Sun-Hyun Kim, Yu Jung Kim, Jeanno Park, Ho Jung Ahn, Hyun Woo Lee, Ivo Kwon, Do-
    Journal of the Korean Medical Association.2018; 61(8): 509.     CrossRef
  • A research study review of effectiveness of treatments for psychiatric conditions common to end-stage cancer patients: needs assessment for future research and an impassioned plea
    Ralph J. Johnson
    BMC Psychiatry.2018;[Epub]     CrossRef
  • Comment on “Asian collaboration to establish a provisional system to provide high‐quality end‐of‐life care by promoting advance care planning for the elderly”
    Dong Wook Shin, Ji Eun Lee, BeLong Cho, Sang Ho Yoo, SangYun Kim, Jun‐Hyun Yoo
    Geriatrics & Gerontology International.2017; 17(4): 672.     CrossRef
  • 12,941 View
  • 102 Download
  • 24 Web of Science
  • 22 Crossref
Close layer
Long-Term Low-Dose Aspirin Use Reduces Gastric Cancer Incidence: A Nationwide Cohort Study
Young-Il Kim, So Young Kim, Ji Hyun Kim, Jun Ho Lee, Young-Woo Kim, Keun Won Ryu, Jong-Hyock Park, Il Ju Choi
Cancer Res Treat. 2016;48(2):798-805.   Published online July 14, 2015
DOI: https://doi.org/10.4143/crt.2015.117
AbstractAbstract PDFPubReaderePub
Purpose
The aim of this study was to investigate whether aspirin use can reduce the incidence of gastric cancer in patients with hypertension or type 2 diabetes. Materials and Methods A total of 200,000 patients with hypertension or type 2 diabetes were randomly selected from the Korean National Health Insurance claim database. Of these, 3,907 patients who used 100 mg of aspirin regularly (regular aspirin users) and 7,808 patients who did not use aspirin regularly (aspirin non-users) were selected at a frequency of 1:2, matched by age, sex, comorbid illnesses (type 2 diabetes and hypertension), and observation periods. The incidence of gastric cancer in this cohort was then assessed during the observation period of 2004 to 2010.
Results
In the matched cohort, the incidence rates of gastric cancer were 0.8% (31/3,907) for regular aspirin users and 1.1% (86/7,808) for aspirin non-users, but the cumulative incidence rates were not significantly different between groups (p=0.116, log-rank test). However, in multivariate analysis, regular aspirin users had a reduced risk of gastric cancer (adjusted hazard ratio [aHR], 0.71; 95% confidential interval [CI], 0.47 to 1.08; p=0.107). Duration of aspirin use showed significant association with reduction of gastric cancer risk (aHR for each year of aspirin use, 0.85; 95% CI, 0.73 to 0.99; p=0.044), particularly in patients who used aspirin for more than 3 years (aHR, 0.40; 95% CI, 0.16 to 0.98; p=0.045). Conclusion Long-term low-dose aspirin use was associated with reduced gastric cancer risk in patients with hypertension or type 2 diabetes.

Citations

Citations to this article as recorded by  
  • Exposure to Commonly Used Drugs and the Risk of Gastric Cancer: An Umbrella Review of Meta-Analyses
    Xiao Bai, Si-Qi Ding, Xue-Ping Zhang, Ming-Hao Han, Dong-Qiu Dai
    Cancers.2023; 15(2): 372.     CrossRef
  • In Vitro Assessment of the Synergistic Effect of Aspirin and 5-Fluorouracil in Colorectal Adenocarcinoma Cells
    Monica Susan, Ioana Macasoi, Iulia Pinzaru, Cristina Dehelean, Iosif Ilia, Razvan Susan, Ioana Ionita
    Current Oncology.2023; 30(7): 6197.     CrossRef
  • Prediction algorithm for gastric cancer in a general population: A validation study
    Martin C. S. Wong, Eman Yee‐man Leung, Sarah T. Y. Yau, Sze Chai Chan, Shaohua Xie, Wanghong Xu, Junjie Huang
    Cancer Medicine.2023; 12(21): 20544.     CrossRef
  • Evaluation of clopidogrel use on gastric precancerous lesions: Does it have chemopreventive effect?
    Taner AKYOL
    Journal of Medicine and Palliative Care.2023; 4(5): 524.     CrossRef
  • Safety and effectiveness of low-dose aspirin for the prevention of gastrointestinal cancer in adults without atherosclerotic cardiovascular disease: a population-based cohort study
    Jessica J P Shami, Jiaxi Zhao, Swathi Pathadka, Eric Yuk Fai Wan, Joseph Edgar Blais, Pareen Vora, Montse Soriano-Gabarró, Ka Shing Cheung, W K Leung, Ian C K Wong, Esther W Chan
    BMJ Open.2022; 12(2): e050510.     CrossRef
  • Association Between Aspirin Use and Gastric Adenocarcinoma: A Prospective Cohort Study
    Sohee Kwon, Wenjie Ma, David A. Drew, Samuel J. Klempner, Brianna M. Leonardo, Jacqueline J. Flynn, Yin Cao, Edward L. Giovannucci, Ying Bao, Charles S. Fuchs, Mingyang Song, Andrew T. Chan
    Cancer Prevention Research.2022; 15(4): 265.     CrossRef
  • Association of Aspirin, Metformin, and Statin Use with Gastric Cancer Incidence and Mortality: A Nationwide Cohort Study
    Mi Hee Cho, Tae Gon Yoo, Su-Min Jeong, Dong Wook Shin
    Cancer Prevention Research.2021; 14(1): 95.     CrossRef
  • Antibreast Cancer Activity of Aspirin-Conjugated Chalcone Polymeric Micelles
    Do Young Lee, Kang Pa Lee, Suji Beak, Ji Su Park, Young Jin Kim, Kil-Nam Kim, Song-Rae Kim, Myeong Sik Yoon
    Macromolecular Research.2021; 29(1): 105.     CrossRef
  • Effect of frequently prescribed drugs on gastric cancer risk
    Theresa Weltermann, Christian Schulz, Lukas Macke
    Best Practice & Research Clinical Gastroenterology.2021; : 101741.     CrossRef
  • Aspirin Use and Common Cancer Risk: A Meta-Analysis of Cohort Studies and Randomized Controlled Trials
    Lijuan Wang, Rongqi Zhang, Lili Yu, Jiarui Xiao, Xuan Zhou, Xinxuan Li, Peige Song, Xue Li
    Frontiers in Oncology.2021;[Epub]     CrossRef
  • The Relationship between Diabetes Mellitus and Gastric Cancer and the Potential Benefits of Metformin: An Extensive Review of the Literature
    Chin-Hsiao Tseng
    Biomolecules.2021; 11(7): 1022.     CrossRef
  • Effect of aspirin use on gastric cancer incidence and survival: A systematic review and meta‐analysis
    Ryota Niikura, Yoshihiro Hirata, Yoku Hayakawa, Takuya Kawahara, Atsuo Yamada, Kazuhiko Koike
    JGH Open.2020; 4(2): 117.     CrossRef
  • Positive association between dietary inflammatory index and gastric cancer risk: A systematic review and meta-analysis
    Ying Liang, Haoyan Jiao, Lingbo Qu, Hao Liu
    Nutrition and Cancer.2020; 72(8): 1290.     CrossRef
  • Efficacy of Aspirin in the Primary Prevention of Cardiovascular Diseases and Cancer in the Elderly: A Population-Based Cohort Study in Korea
    Minji Jung, Sukhyang Lee
    Drugs & Aging.2020; 37(1): 43.     CrossRef
  • Safety of Proton Pump Inhibitors Questioned Based on a Large Randomized Trial of Patients Receiving Rivaroxaban or Aspirin
    Johanna Simin, Qing Liu, Romina Fornes, Nele Brusselaers
    Gastroenterology.2020; 158(4): 1172.     CrossRef
  • De novo malignancy risk in patients undergoing the first percutaneous coronary intervention: A nationwide population-based cohort study
    Soongu Kwak, You-Jung Choi, Soonil Kwon, Seo-Young Lee, Seokhun Yang, Inki Moon, Hyun-Jung Lee, Heesun Lee, Jun-Bean Park, Kyungdo Han, Yong-Jin Kim, Hyung-Kwan Kim
    International Journal of Cardiology.2020; 313: 25.     CrossRef
  • Use of proton pump inhibitors and histamine-2 receptor antagonists and risk of gastric cancer in two population-based studies
    Peipei Liu, Úna C. McMenamin, Brian T. Johnston, Peter Murchie, Lisa Iversen, Amanda J. Lee, Pauline A. J. Vissers, Chris R. Cardwell
    British Journal of Cancer.2020; 123(2): 307.     CrossRef
  • Low‐dose aspirin and risk of gastric and oesophageal cancer: A population‐based study in the United Kingdom using The Health Improvement Network
    Luis A. García Rodríguez, Montse Soriano‐Gabarró, Pareen Vora, Lucía Cea Soriano
    International Journal of Cancer.2020; 147(9): 2394.     CrossRef
  • Preventing Metachronous Gastric Cancer after the Endoscopic Resection of Gastric Epithelial Neoplasia: Roles of Helicobacter pylori Eradication and Aspirin
    Jiro Watari, Toshihiko Tomita, Katsuyuki Tozawa, Tadayuki Oshima, Hirokazu Fukui, Hiroto Miwa
    Gut and Liver.2020; 14(3): 281.     CrossRef
  • Acetylsalicylic Acid Exerts Potent Antitumor and Antiangiogenic Effects in Cutaneous and Uveal Melanoma Cell Lines
    Dominique Fausto de Souza, Thupten Tsering, Miguel N. Burnier , Vasco Bravo-Filho, Ana Beatriz Toledo Dias, Mohamed Abdouh, Alicia Goyeneche, Julia Valdemarin Burnier
    Ocular Oncology and Pathology.2020; 6(6): 442.     CrossRef
  • Associations between aspirin use and the risk of cancers: a meta-analysis of observational studies
    Yan Qiao, Tingting Yang, Yong Gan, Wenzhen Li, Chao Wang, Yanhong Gong, Zuxun Lu
    BMC Cancer.2018;[Epub]     CrossRef
  • Cumulative Dose Threshold for the Chemopreventive Effect of Aspirin Against Gastric Cancer
    Min-hyung Kim, Jooyoung Chang, Warrick Junsuk Kim, Samprit Banerjee, Sang Min Park
    American Journal of Gastroenterology.2018; 113(6): 845.     CrossRef
  • Aspirin associated with risk reduction of secondary primary cancer for patients with head and neck cancer: A population-based analysis
    Yu-Shan Lin, Chih-Ching Yeh, Shiang-Fu Huang, Yi-Sheng Chou, Li-Tang Kuo, Fung-Chang Sung, Chih-Hsin Muo, Chien-Tien Su, Fu-Hsiung Su, Mohammad R. Akbari
    PLOS ONE.2018; 13(8): e0199014.     CrossRef
  • Cumulative Dose Threshold for the Chemopreventive Effect of Aspirin Against Gastric Cancer
    Min-hyung Kim, Jooyoung Chang, Warrick Junsuk Kim, Samprit Banerjee, Sang Min Park
    American Journal of Gastroenterology.2018; 113(6): 845.     CrossRef
  • Chemoprevention of Gastric Cancer: Non-steroidal Anti-inflammatory Drugs Including Aspirin
    Kee Don Choi
    The Korean Journal of Helicobacter and Upper Gastrointestinal Research.2017; 17(4): 169.     CrossRef
  • Effects of long-term aspirin use on molecular alterations in precancerous gastric mucosa in patients with and without gastric cancer
    Yuki Michigami, Jiro Watari, Chiyomi Ito, Ken Hara, Takahisa Yamasaki, Takashi Kondo, Tomoaki Kono, Katsuyuki Tozawa, Toshihiko Tomita, Tadayuki Oshima, Hirokazu Fukui, Takeshi Morimoto, Kiron M. Das, Hiroto Miwa
    Scientific Reports.2017;[Epub]     CrossRef
  • Aspirin enhances the cytotoxic activity of bortezomib against myeloma cells via suppression of Bcl-2, survivin and phosphorylation of AKT
    Jiang-Hua Ding, Li-Ya Yuan, Guo-An Chen
    Oncology Letters.2017; 13(2): 647.     CrossRef
  • Aspirin and non-steroidal anti-inflammatory drugs use reduce gastric cancer risk: A dose-response meta-analysis
    Xuan-zhang Huang, You Chen, Jian Wu, Xi Zhang, Cong-cong Wu, Chao-ying Zhang, Shuang-shuang Sun, Wen-jun Chen
    Oncotarget.2017; 8(3): 4781.     CrossRef
  • Prognostic value of a novel FPR biomarker in patients with surgical stage II and III gastric cancer
    Jing Zhang, Shu-Qi Li, Zhi-Hua Liao, Yu-Huan Jiang, Qing-Gen Chen, Bo Huang, Jing Liu, Yan-Mei Xu, Jin Lin, Hou-Qun Ying, Xiao-Zhong Wang
    Oncotarget.2017; 8(43): 75195.     CrossRef
  • Dietary inflammatory index and the risk of gastric cancer in a Korean population
    Sunghee Lee, Jeonghee Lee, Il Ju Choi, Young-Woo Kim, Keun Won Ryu, Young-Il Kim, Jin-Kyoung Oh, Binh Thang Tran, Jeongseon Kim
    Oncotarget.2017; 8(49): 85452.     CrossRef
  • 13,034 View
  • 182 Download
  • 35 Web of Science
  • 30 Crossref
Close layer
Negative Public Attitudes towards Cancer Survivors Returning to Work: A Nationwide Survey in Korea
Hye-Young Shim, Ji-Yeon Shin, Jong Heun Kim, So-Young Kim, Hyung-Kook Yang, Jong-Hyock Park
Cancer Res Treat. 2016;48(2):815-824.   Published online June 5, 2015
DOI: https://doi.org/10.4143/crt.2015.094
AbstractAbstract PDFPubReaderePub
Purpose
Early diagnosis and an improved survival rate have emerged as important issues for cancer survivors returning to work during the prime of their working life. This study investigated the attitudes of the general public towards cancer survivors returning to work in Korea and attempted to identify the factors influencing this negative attitude. Materials and Methods A general public perception survey regarding cancer survivors returning to work, targeting 2,000 individuals between 40-70 years of age, was conducted as face-to-face home visit.
Results
The public expressed a negative attitude towards cancer survivors returning to work, in terms of both perception and acceptance. Negative perception was higher among those in metropolitan areas compared with urban/rural areas (odds ratio [OR], 1.71), with monthly incomes < $2,000 compared with > $4,000 (OR, 1.54), and with patient care experience compared with those without (OR, 1.41). Negative acceptance was higher among those with monthly incomes < $2,000 compared with > $4,000 (OR, 1.71) and those with patient care experience compared with those without (OR, 1.54). The common factors between acceptance and perception that influenced negative attitude included area of residence, patient care experience, and monthly income. Conclusion This study identified negative attitudes towards cancer survivors returning to work in South Korea and the factors influencing the reintegration of cancer survivors into society. It is necessary to promote community awareness and intervention activities to enable access to community, social, and individual units for the social reintegration of cancer survivors.

Citations

Citations to this article as recorded by  
  • Role performance and factors affecting quality of life in bladder cancer survivors with ileal orthotopic neobladder
    So Hee Kim, Eunjung Ryu, Byong Chang Jeong
    Asia-Pacific Journal of Oncology Nursing.2024; 11(6): 100490.     CrossRef
  • Perception of Korean healthy adolescents on cancer and adolescent cancer survivors: a cross-sectional survey
    Min Kyung Hyun, Yeonseung Lee, Hyun Jeong Lee, Young Ae Kim
    BMC Public Health.2024;[Epub]     CrossRef
  • Employees’ attitudes toward cancer, cancer survivors, and cancer survivors’ return to work
    Si Eun Lee, Eun Young Park
    Asia-Pacific Journal of Oncology Nursing.2023; 10(3): 100197.     CrossRef
  • In What Ways Does Health Related Stigma Affect Sustainable Employment and Well-Being at Work? A Systematic Review
    I. E. van Beukering, S. J. C. Smits, K. M. E. Janssens, R. I. Bogaers, M. C. W. Joosen, M. Bakker, J. van Weeghel, E. P. M. Brouwers
    Journal of Occupational Rehabilitation.2022; 32(3): 365.     CrossRef
  • Effects of Stigma on the Relationship Between Perceived Social Support and Sexual Satisfaction Among Breast Cancer Survivors
    Yuxin Zhang, Jie Zhao, Nan Jiang, Ting Wang, He Cao, Quqing Wang, Xiaomin Wei, Jiwei Wang, Jinming Yu
    The Journal of Sexual Medicine.2022; 19(6): 1002.     CrossRef
  • The transcultural adaptation and validation of the Chinese version of the Attitudes Toward Recognizing Early and Noticeable Deterioration scale
    Wenbo Li, Hongyu Yu, Bing Li, Yanli Zhang, Mingshu Fu
    Frontiers in Psychology.2022;[Epub]     CrossRef
  • Cross-cultural validation of the Cancer Stigma Scale in the general Japanese population
    Emi Takeuchi, Daisuke Fujisawa, Rina Miyawaki, Hiroko Yako-Suketomo, Koichiro Oka, Masaru Mimura, Miyako Takahashi
    Palliative and Supportive Care.2021; 19(1): 75.     CrossRef
  • Association between cancer stigma and job loss among cancer survivors
    Sungkeun Shim, Danbee Kang, Ka Ryeong Bae, Woo Yong Lee, Seok Jin Nam, Tae Sung Sohn, Byong Chang Jeong, Dong Hyun Sinn, Sun Seog Kweon, Young Mog Shim, Juhee Cho
    Psycho-Oncology.2021; 30(8): 1347.     CrossRef
  • Empathic approach to reducing the negative attitudes of nursing undergraduate students towards cancer
    Hamdiye Arda Sürücü, Esra Anuş Topdemir, Altun Baksi, Dilek Büyükkaya Besen
    Nurse Education Today.2021; 105: 105039.     CrossRef
  • Identification of Korean cancer survivors’ unmet needs and desired psychosocial assistance: A focus group study
    Joo Young Kim, Mison Chun, Sang-Won Kim, Joonsup Song, Rosemary Frey
    PLOS ONE.2020; 15(1): e0228054.     CrossRef
  • Self-reported depression in cancer survivors versus the general population: a population-based propensity score-matching analysis
    Su Jung Lee, Kathleen B. Cartmell
    Quality of Life Research.2020; 29(2): 483.     CrossRef
  • Public Attitudes towards Cancer Survivors among Korean Adults
    Su Yeon Kye, Hyun Jeong Lee, Yeonseung Lee, Young Ae Kim
    Cancer Research and Treatment.2020; 52(3): 722.     CrossRef
  • A return-to-work intervention protocol directed at cancer patients (self-assessment, tailored information & lifestyle management for returning to work among cancer patients, START): A multi-center, randomized controlled trial
    Ka Ryeong Bae, Danbee Kang, Jae Yoon Yi, Yeojin Ahn, Im-Ryung Kim, Sun-Seog Kweon, Jin Seok Ahn, Seok Jin Nam, Young Mog Shim, Mison Chun, Jaesung Heo, Juhee Cho
    Contemporary Clinical Trials Communications.2020; 19: 100633.     CrossRef
  • Relationship between cancer stigma, social support, coping strategies and psychosocial adjustment among breast cancer survivors
    No Eul Kang, Hye Young Kim, Ji Young Kim, Sung Reul Kim
    Journal of Clinical Nursing.2020; 29(21-22): 4368.     CrossRef
  • The Effects of a Culturally Tailored, Patient-Centered Psychosocial Intervention in South Korean Cancer Survivors
    Dohun Kim, Sun Ju Chang, Hyun Ok Lee, Seung Hee Lee
    Clinical Nursing Research.2019; 28(8): 931.     CrossRef
  • Evaluation of the First Polish Web-Based Intervention Aimed at Improving Cancer Prevention (the PORINA Study)
    Maksymilian Gajda, Małgorzata Kowalska, Jan E. Zejda
    International Journal of Environmental Research and Public Health.2018; 15(6): 1167.     CrossRef
  • 15,875 View
  • 145 Download
  • 19 Web of Science
  • 16 Crossref
Close layer
Family Avoidance of Communication about Cancer: A Dyadic Examination
Dong Wook Shin, Jooyeon Shin, So Young Kim, Hyung-Kook Yang, Juhee Cho, Jung Ho Youm, Gyu Seog Choi, Nam Soo Hong, BeLong Cho, Jong-Hyock Park
Cancer Res Treat. 2016;48(1):384-392.   Published online March 13, 2015
DOI: https://doi.org/10.4143/crt.2014.280
AbstractAbstract PDFPubReaderePub
Purpose
This study aimed to examine the following questions: to what extent do patients and caregivers perceive their family members to be avoidant of communication regarding patient’s cancer, and to what extent do these perceptions interrelate; and how do such perceptions influence their own and each other’s communication behaviors, communication outcome, mental health, and quality of life. Materials and Methods A national survey was performed with 990 patient-caregiver dyads (participation rate, 76.2%). To examine the dyadic interaction, we developed linked patient and family member questionnaires, including the Family Avoidance of Communication about Cancer (FACC) scale. Results The mean scores (standard deviations) of patient- and caregiver-perceived FACC were low at 10.9 (15.5) and 15.5 (17.5), respectively (p < 0.001), and concordance was low, a well (Spearman’s rho, 0.23). Patient-perceived FACC was associated with lower levels of disclosure and behaviors of holding back communication, as well as lower levels of mental health outcome and quality of life. The same was true for caregivers (all p < 0.05). Patient-perceived FACC was associated with caregiver holding back, caregiver’s depression level, and caregiver quality of life (all p < 0.05). Both patient- and caregiver-perceived FACC were independently associated with communication difficulty within the family. Conclusion Future research would benefit from the measurement of FACC from both patients and caregivers, and promote family intervention to enhance openness to communication, which would be helpful for improving mental health and quality of life for both patients and caregivers.

Citations

Citations to this article as recorded by  
  • Dyadic association between mindfulness, family avoidance of communication about cancer and fear of cancer recurrence among breast cancer couples: A cross-sectional study
    Xiangyu Zhao, Yunxue Zhang, Rui Qin, Guopeng Li, Xudong He, Xiaona Shen, Ping Li
    European Journal of Oncology Nursing.2024; 68: 102491.     CrossRef
  • Caring for a Parent With a Blood Cancer: Sibling Communication Challenges and Psychosocial Outcomes
    Kevin B. Wright, Carma L. Bylund, Diliara Bagautdinova, Chelsea N. Hampton, Gemme Campbell-Salome, Elisa S. Weiss, Maria Sae-Hau, Carla L. Fisher
    Families in Society: The Journal of Contemporary Social Services.2024;[Epub]     CrossRef
  • Understanding the patient-spouse communication experience during chemotherapy for gastric cancer: A qualitative study
    Ye Zhou, Chong Chin Che, Mei Chan Chong, Yuzhu Hou, Xiangqun Xiao, Yun Liu, Haiyan Zhao
    Journal of Psychosocial Oncology.2024; : 1.     CrossRef
  • Cancer Caregivers’ Prognostic and End-of-Life Communication Needs and Experiences and their Impact
    Anny T.H.R. Fenton, Kalen M. Fletcher, Deniz Kizildag, Nancy A. Borstelmann, Daniela Kessler, Christine Cronin, Anna C. Revette, Alexi A. Wright, Elizabeth Frank, Andrea C. Enzinger
    Journal of Pain and Symptom Management.2023; 65(1): 16.     CrossRef
  • Relationships Among Perceived Social Support, Family Resilience, and Caregiver Burden in Lung Cancer Families: A Mediating Model
    Yalin Zhang, Yuxin Ding, Chunhua Liu, Juejin Li, Qi Wang, Yunhuan Li, Xiaolin Hu
    Seminars in Oncology Nursing.2023; 39(3): 151356.     CrossRef
  • Exploring Dyad-Based Communication During Cancer
    Martha E. Francis, Pranshu Mohindra, Kim Mooney-Doyle
    Cancer Nursing.2023; 46(6): E384.     CrossRef
  • Contributors to well‐being of Chinese left‐behind families: A dyadic perspective from family resilience and grandparent–grandchild relationship
    Qiong Hu, Yanlin Zhou, Peiqi Dong, Cihua Xu, Qiong Zhang
    Child & Family Social Work.2023; 28(3): 646.     CrossRef
  • The perception of life and death in patients with end-of-life stage cancer: A systematic review of qualitative research
    Ayumi Kyota, Kiyoko Kanda, Maiko Senuma, Noriko Tsukagoshi, Tamae Futawatari, Yuka Kondo
    European Journal of Oncology Nursing.2023; 66: 102354.     CrossRef
  • Communication with cancer patients: the perspective of caregivers versus non-caregivers in Iran
    Azam Naghavi, Samaneh Salimi, Winfried Rief, Pia von Blanckenburg
    Frontiers in Psychology.2023;[Epub]     CrossRef
  • Caregiver burden among family caregivers of patients with advanced cancer in a palliative context: A mixed‐method study
    Yalin Zhang, Shu Zhang, Chunhua Liu, Xiaoli Chen, Yuxin Ding, Chang Guan, Xiaolin Hu
    Journal of Clinical Nursing.2023; 32(21-22): 7751.     CrossRef
  • Distinct dyadic quality of life profiles among patient-caregiver dyads with advanced lung cancer: a latent profile analysis
    Hui Wang, Tiantian Deng, Cong Cao, Danjun Feng
    Supportive Care in Cancer.2023;[Epub]     CrossRef
  • Family communication and coping among racial‐ethnic minority cancer patients: A systematic review
    Yu‐Ju Huang, Chiara Acquati, Monit Cheung
    Health & Social Care in the Community.2022;[Epub]     CrossRef
  • Barriers to seeking psychosocial support among adult patients with hematologic neoplasms: a qualitative study
    Mengting Xie, Chunfeng Wang, Jingyi Chen, Ying Wang, Xiaoxia Wu, Yong Wu, Rong Hu
    Supportive Care in Cancer.2022; 30(3): 2613.     CrossRef
  • Openness and topic avoidance in interpersonal communication about ovarian cancer: An uncertainty management perspective
    Dinah A. Tetteh, Najma Akhther
    Qualitative Research in Medicine and Healthcare.2022;[Epub]     CrossRef
  • Patient-caregiver communication concordance in cancer—refinement of the Cancer Communication Assessment Tool in an Australian sample
    Natasha Michael, Alex Gorelik, Ekavi Georgousopoulou, Merlina Sulistio, Patrick Tee, Katherine Hauser, David Kissane
    Supportive Care in Cancer.2022; 30(9): 7387.     CrossRef
  • The role of caregivers in the clinical pathway of patients newly diagnosed with breast and prostate cancer: A study protocol
    Clizia Cincidda, Serena Oliveri, Virginia Sanchini, Gabriella Pravettoni
    Frontiers in Psychology.2022;[Epub]     CrossRef
  • Efficacy of a dyadic intervention to improve communication between patients with cancer and their caregivers: A randomized pilot trial
    Julien Tiete, Nicole Delvaux, Aurore Liénard, Darius Razavi
    Patient Education and Counseling.2021; 104(3): 563.     CrossRef
  • Hostility in cancer patients as an underexplored facet of distress
    Luigi Grassi, Martino Belvederi Murri, Michelle Riba, Silvia de Padova, Tatiana Bertelli, Silvana Sabato, Maria Giulia Nanni, Rosangela Caruso, Heifa Ounalli, Luigi Zerbinati
    Psycho-Oncology.2021; 30(4): 493.     CrossRef
  • Effects of family participatory dignity therapy on the psychological well-being and family function of patients with haematologic malignancies and their family caregivers: A randomised controlled trial
    Chunfeng Wang, Jingyi Chen, Ying Wang, Wenkui Xu, Mengting Xie, Yong Wu, Rong Hu
    International Journal of Nursing Studies.2021; 118: 103922.     CrossRef
  • The effect of death anxiety in nurses on their approach to dying patients: A cross‐sectional study
    Adalet Üstükuş, Zehra Eskimez
    Perspectives in Psychiatric Care.2021; 57(4): 1929.     CrossRef
  • Dyadic effects of family-functioning and resilience on quality of life in advanced lung cancer patients and caregivers: An actor-partner interdependence mediation model
    Hui Wang, Haorun Yue, Minmin Ren, Danjun Feng
    European Journal of Oncology Nursing.2021; 52: 101963.     CrossRef
  • Multiple approaches to enhancing cancer communication in the next decade: translating research into practice and policy
    Claire C Conley, Amy K Otto, Glynnis A McDonnell, Kenneth P Tercyak
    Translational Behavioral Medicine.2021; 11(11): 2018.     CrossRef
  • The Dyadic Cancer Outcomes Framework: A general framework of the effects of cancer on patients and informal caregivers
    Tess Thompson, Dana Ketcher, Tamryn F. Gray, Erin E. Kent
    Social Science & Medicine.2021; 287: 114357.     CrossRef
  • The Self-Efficacy to Communicate about Sex and Intimacy (SECSI) scale: psychometric assessment in women treated for cancer
    Elizabeth K. Arthur, Celia E. Wills, Kristine Browning, Janine Overcash, Usha Menon
    Supportive Care in Cancer.2020; 28(3): 1449.     CrossRef
  • The Critical Need to Recognize That Families Matter for Adult Health: A Systematic Review of the Literature
    Sarah B. Woods, Kate Bridges, Erica N. Carpenter
    Family Process.2020; 59(4): 1608.     CrossRef
  • Family Communication Patterns and Challenges of Huntington’s Disease Risk, the Decision to Pursue Presymptomatic Testing, and Test Results
    Kelsey Stuttgen, Juli Bollinger, Allison McCague, Rachel Dvoskin, Debra Mathews
    Journal of Huntington's Disease.2020; 9(3): 265.     CrossRef
  • Open communication between caregivers’ and terminally ill cancer patients about illness and death: The role of gender - A correlational study
    Sara Carmel, Yoram Singer, Nili Yosef-Sela, Yaacov G. Bachner
    European Journal of Oncology Nursing.2020; 49: 101828.     CrossRef
  • Patient-family communication mediates the relation between family hardiness and caregiver positivity: Exploring the moderating role of caregiver depression and anxiety
    Joo Yeon Shin, Michael F. Steger, Dong Wook Shin, So Young Kim, Hyung-Kook Yang, Juhee Cho, Ansuk Jeong, Keeho Park, Sun Seog Kweon, Jong-Hyock Park
    Journal of Psychosocial Oncology.2019; 37(5): 557.     CrossRef
  • Reports of Sharing and Withholding Cancer-Related Information by Patients With Gynecologic Cancer and Their Supporters
    Maria Checton, Maria Venetis, Danielle Catona, Allyson Bontempo, Kathryn Greene, Alexandre de Meritens, Katie Devine
    Oncology Nursing Forum.2019; 46(6): 676.     CrossRef
  • Family Members’ Experiences With Dialysis and Kidney Transplantation
    Nicole DePasquale, Ashley Cabacungan, Patti L. Ephraim, LaPricia Lewis-Boyér, Neil R. Powe, L. Ebony Boulware
    Kidney Medicine.2019; 1(4): 171.     CrossRef
  • The relationship between holding back from communicating about breast concerns and anxiety in the year following breast biopsy
    Caroline S. Dorfman, Eneka Lamb, Alyssa Van Denburg, Anava A. Wren, Mary Scott Soo, Kaylee Faircloth, Vicky Gandhi, Rebecca A. Shelby
    Journal of Psychosocial Oncology.2018; 36(2): 222.     CrossRef
  • Underestimated caregiver burden by cancer patients and its association with quality of life, depression and anxiety among caregivers
    J.Y. Shin, J.-W. Lim, D.W. Shin, S.Y. Kim, H.-K. Yang, J. Cho, A. Jeong, D. Jo, C.-Y. Yim, K. Park, J.-H. Park
    European Journal of Cancer Care.2018; 27(2): e12814.     CrossRef
  • The Dyadic Effects of Family Cohesion and Communication on Health-Related Quality of Life: The Moderating Role of Sex
    Jung-won Lim, En-jung Shon
    Cancer Nursing.2018; 41(2): 156.     CrossRef
  • 12,519 View
  • 134 Download
  • 34 Web of Science
  • 33 Crossref
Close layer
Medical Costs and Healthcare Utilization among Cancer Decedents in the Last Year of Life in 2009
Inuk Hwang, Dong Wook Shin, Kyoung Hee Kang, Hyung Kook Yang, So Young Kim, Jong-Hyock Park
Cancer Res Treat. 2016;48(1):365-375.   Published online March 2, 2015
DOI: https://doi.org/10.4143/crt.2014.088
AbstractAbstract PDFPubReaderePub
Purpose
The purpose of this study was to evaluate the cancer care cost during the last year of life of patients in Korea. Materials and Methods We studied the breakdown of spending on the components of cancer care. Cancer decedents in 2009 were identified from the Korean Central Cancer Registry and linked with the Korean National Health Insurance Claims Database. The final number of patients included in the study was 70,558.
Results
In 2009, the average cancer care cost during the last year of life was US $15,720. Patients under age 20 spent US $53,890 while those 70 or over spent US $11,801. Those with leukemia incurred the highest costs (US $43,219) while bladder cancer patients spent the least (US $13,155). General costs, drugs other than analgesics, and test fees were relatively high (29.7%, 23.8%, and 20.7% of total medical costs, respectively). Analgesic drugs, rehabilitation, and psychotherapy were still relatively low (4.3%, 0.7%, and 0.1%, respectively). Among the results of multiple regression analysis, few were notable. Age was found to be negatively related to cancer care costs while income level was positively associated. Those classified under distant Surveillance, Epidemiology, and End Results stages of cancer and higher comorbidity level also incurred higher cancer care costs. Conclusion Average cancer care costs varied significantly by patient characteristics. However, the study results suggest an underutilization of support services likely due to lack of alternative accommodations for terminal cancer patients. Further examination of utilization patterns of healthcare resources will help provide tailored evidence for policymakers in efforts to reduce the burdens of cancer care.

Citations

Citations to this article as recorded by  
  • Patterns of Medical Utilization in Children, Adolescents, and Young Adults With Life-Limiting Conditions in Korea: A Cohort Study Based on National Health Insurance Data
    Seonhwa Lee, Byungmi Kim, Jin Young Choi, So-Jung Park, Jun Ah Lee, Chung Ho Kim, Bomi Park, Bohyun Park
    Journal of Korean Medical Science.2025;[Epub]     CrossRef
  • Medical care costs at the end of life among older adults with cancer: a national health insurance data-based cohort study
    Minjeong Jo, Yunji Lee, Taehwa Kim
    BMC Palliative Care.2023;[Epub]     CrossRef
  • Medical cost of advanced illnesses in the last-year of life—retrospective database study
    Palvinder Kaur, Huei Yaw Wu, Allyn Hum, Bee Hoon Heng, Woan Shin Tan
    Age and Ageing.2022;[Epub]     CrossRef
  • Projecting Lifetime Health Outcomes and Costs Associated with the Ambient Fine Particulate Matter Exposure among Adult Women in Korea
    Gyeyoung Choi, Yujeong Kim, Gyeongseon Shin, SeungJin Bae
    International Journal of Environmental Research and Public Health.2022; 19(5): 2494.     CrossRef
  • Disparities in healthcare expenditures according to economic status in cancer patients undergoing end-of-life care
    Kyu-Tae Han, Woorim Kim, Seungju Kim
    BMC Cancer.2022;[Epub]     CrossRef
  • Healthcare resource utilization and medical costs in patients with terminal cancer during best supportive care
    Dong-Won Kang, Yoon-Bo Shim, Eui-Kyung Lee, Mi-Hai Park, Wen-Chi Chou
    PLOS ONE.2022; 17(6): e0269565.     CrossRef
  • Trends in End-of-Life Resource Utilization and Costs among Prostate Cancer Patients from 2006 to 2015: A Nationwide Population-Based Study
    Yun-Sok Ha, So-Young Kim, Jae Il Chung, Hoon Choi, Jae Heon Kim, Ho Song Yu, In-Chang Cho, Hyung Joon Kim, Hyun Chul Chung, Jun Sung Koh, Ji Youl Lee, Dong Jin Park, Hyun Tae Kim, Eun Sang Yoo, Tae Gyun Kwon, Kyungchan Min, Wun-Jae Kim, Seok Joong Yun, Jo
    The World Journal of Men's Health.2021; 39(1): 158.     CrossRef
  • End-of-life cost trajectories and the trade-off between treatment costs and life-extension: Findings from the Cost and Medical Care of Patients with Advanced Serious Illness (COMPASS) cohort study
    Brett Doble, Wei Han Melvin Wong, Eric Finkelstein
    Palliative Medicine.2021; 35(5): 893.     CrossRef
  • Evolution of health care utilization and expenditure during the year before death in 2015 among people with cancer: French snds-based cohort study
    Audrey Tanguy-Melac, Dorian Verboux, Laurence Pestel, Anne Fagot-Campagna, Philippe Tuppin, Christelle Gastaldi-Ménager
    The European Journal of Health Economics.2021; 22(7): 1039.     CrossRef
  • How the resource allocation and inpatient behavior affect the expenditures of terminal malignant tumor patients?
    Fen Li, Bifan Zhu, Peimin Sang, Chunlin Jin
    Journal of Cancer Policy.2020; 25: 100249.     CrossRef
  • Cost of Care and Pattern of Medical Care Use in the Last Year of Life among Long-Term Care Insurance Beneficiaries in South Korea: Using National Claims Data
    Sunjoo Boo, Jungah Lee, Hyunjin Oh
    International Journal of Environmental Research and Public Health.2020; 17(23): 9078.     CrossRef
  • The Last Year Before Graft Failure Negatively Impacts Economic Outcomes and is Associated With Greater Healthcare Resource Utilization Compared With Previous Years in the United Kingdom: Results of a Retrospective Observational Study
    Gorden Muduma, Varuna Aluvihare, Marc Clancy, Enrico de Nigris, Carolyn Whitlock, Margarita Landeira, Jameel Nazir
    Transplantation Direct.2019; 5(5): e443.     CrossRef
  • National practice patterns and direct medical costs for prostate cancer in Korea across a 10 year period: a nationwide population-based study using a national health insurance database
    Ho Won Kang, Seok-Joong Yun, Jae Il Chung, Hoon Choi, Jae Heon Kim, Ho Song Yu, Yun-Sok Ha, In-Chang Cho, Hyung Joon Kim, Hyun Chul Chung, Jun Sung Koh, Wun-Jae Kim, Jong-Hyock Park, Ji Youl Lee, So-Young Kim
    BMC Health Services Research.2019;[Epub]     CrossRef
  • Budget impact analysis of gene expression tests to aid therapy decisions for breast cancer patients in Germany
    M.P. Lux, N. Nabieva, T. Hildebrandt, H. Rebscher, S. Kümmel, J.-U. Blohmer, M.G. Schrauder
    The Breast.2018; 37: 89.     CrossRef
  • Intensity of Care at the End of Life Among Older Adults in Korea
    Su Hyun Kim, Sangwook Kang, Mi-Kyung Song
    Journal of Palliative Care.2018; 33(1): 47.     CrossRef
  • Gasto en el último año de vida para pacientes que mueren con cáncer
    Sergio I. Prada, Juan F. Contreras
    Revista Colombiana de Cancerología.2018; 22(1): 3.     CrossRef
  • Medical care costs of cancer in the last year of life using national health insurance data in Korea
    Mihai Park, Inmyung Song, M Barton Laws
    PLOS ONE.2018; 13(6): e0197891.     CrossRef
  • The Effect of Hospice Consultation on Aggressive Treatment of Lung Cancer
    Shin Hye Yoo, Bhumsuk Keam, Miso Kim, Tae Min Kim, Dong-Wan Kim, Dae Seog Heo
    Cancer Research and Treatment.2018; 50(3): 720.     CrossRef
  • Evaluation of the Cost of Comprehensive Outpatient Therapies in Patients with Malignant Brain Tumors
    Stacy McCarty, Susan Keeshin, Sarah M. Eickmeyer, Samman Shahpar, Patrick Semik, Alex W. K. Wong
    American Journal of Physical Medicine & Rehabilitation.2017; 96(5): 341.     CrossRef
  • Health care services utilization during the last 6 months of life among patients with bladder cancer who underwent radical cystectomy in Quebec, Canada
    Ahmed S. Zakaria, Fabiano Santos, Alice Dragomir, Wassim Kassouf, Simon Tanguay, Armen Aprikian
    Urologic Oncology: Seminars and Original Investigations.2017; 35(9): 539.e1.     CrossRef
  • Joint Symposium of Korean Cancer Association & UICC-ARO—Cross-boundary cancer studies: cancer and Universal Health Coverage (UHC) in Asia
    Eun-Cheol Park, Norie Kawahara, Shinjiro Nozaki, Hasbullah Thabrany, Shunya Yoshimi, Sohee Park, Duk Hyoung Lee, Hideyuki Akaza, Jae Kyung Roh
    Japanese Journal of Clinical Oncology.2017; 47(9): 889.     CrossRef
  • Escalating Health Care Expenditures in Cancer Decedents’ Last Year of Life: A Decade of Evidence from a Retrospective Population-Based Cohort Study in Taiwan
    Yen-Ni Hung, Tsang-Wu Liu, Fur-Hsing Wen, Wen-Chi Chou, Siew Tzuh Tang
    The Oncologist.2017; 22(4): 460.     CrossRef
  • 11,534 View
  • 122 Download
  • 26 Web of Science
  • 22 Crossref
Close layer

Cancer Res Treat : Cancer Research and Treatment
Close layer
TOP